|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400093951 |
|
最近更新日期: Date of Last Refreshed on: |
2024-12-13 17:17:51 |
|
注册时间: Date of Registration: |
2024-12-13 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
广州市≤5岁婴幼儿家长手足口病认知现状及健康教育干预效果研究 |
|
Public title: |
Study on the current status of hand, foot and mouth disease cognition and the effect of health education intervention among parents of infants and young children aged <= 5 years in Guangzhou |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
广州市≤5岁婴幼儿手足口病认知现状及健康教育干预效果研究 |
|
Scientific title: |
A Study on the Knowledge of Hand, Foot, and Mouth Disease and the Effectiveness of Health Education Interventions in Infants and Young Children Aged <=5 Years in Guangzhou |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘佼佼 |
研究负责人: |
刘佼佼 |
|
Applicant: |
Jiaojiao Liu |
Study leader: |
Jiaojiao Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 185 0748 7071 |
研究负责人电话:
Study leader's |
+86 185 0748 7071 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
liu18507487071@163.com |
研究负责人电子邮件: Study leader's E-mail: |
liu18507487071@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广州市疾病预防控制中心 |
研究负责人通讯地址: |
广州市疾病预防控制中心 |
|
Applicant address: |
Guangzhou Center for Disease Control and Prevention |
Study leader's address: |
Guangzhou Center for Disease Control and Prevention |
|
申请注册联系人邮政编码: Applicant postcode: |
510440 |
研究负责人邮政编码: Study leader's postcode: |
510440 |
|
申请人所在单位: |
广州市疾病预防控制中心 |
||
|
Applicant's institution: |
Guangzhou Center for Disease Control and Prevention |
||
|
研究负责人所在单位: |
广州市疾病预防控制中心 |
||
|
Affiliation of the Leader: |
Guangzhou Center for Disease Control and Prevention |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
GZCDC-ECHR-2023P0072 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
广州市疾病预防控制中心伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Guangzhou Center for Disease Control and Prevention |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-09-01 00:00:00 | ||
|
伦理委员会联系人: |
孙敏英 |
||
|
Contact Name of the ethic committee: |
Minying Sun |
||
|
伦理委员会联系地址: |
广州市白云区嘉禾启德路1号 |
||
|
Contact Address of the ethic committee: |
No. 1, Qide Road, Jiahe, Baiyun District, Guangzhou |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 36055857 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
广州市疾病预防控制中心 |
||||||||||||||||||||||
|
Primary sponsor: |
Guangzhou Center for Disease Control and Prevention |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广州市白云区嘉禾启德路1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1, Qide Road, Jiahe, Baiyun District, Guangzhou |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
广州市疾病预防控制中心 |
||||||||||||||||||||||
|
Source(s) of funding: |
Guangzhou Center for Disease Control and Prevention |
||||||||||||||||||||||
|
研究疾病: |
手足口病 |
||||||||||||||||||||||
|
Target disease: |
Hand, Foot, and Mouth Disease |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
整群随机分组 |
||||||||||||||||||||||
|
Study design: |
Cluster randomization |
||||||||||||||||||||||
|
研究目的: |
在一项整群随机试验中调查联合健康教育是否可以降低手足口病的发病密度以及推迟疾病发病。 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate in a cluster randomized trial whether a combined health education intervention can reduce the incidence rate of hand, foot, and mouth disease and delay the onset of the disease in infants and young children. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)广州市常住居民;(2)家中至少有一个 3 岁及以下的儿童。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) permanent residency in Guangzhou; (2) having at least one child aged 3 years or younger in the household. |
||||||||||||||||||||||
|
排除标准: |
(1)问卷回答不完整;(2)联系方式不正确,无法跟进随访; (3)随访前婴幼儿发病。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Incomplete answers to the questionnaire; (2) Incorrect contact details and no follow-up was possible; (3) Onset of disease in infants and young children before follow-up. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-02-15 00:00:00至 To 2024-10-10 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-11-23 00:00:00 至 To 2024-01-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
基于对 2013 年至 2022 年手足口病发病热点的分析,将广州分为热点区、随机区和冷区三个区域。从每个区域随机选择两个区,从每个区随机选择两个 CHC。然后使用计算机生成的随机数将这些选定的 CHC 随机分配到干预组或对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Based on an analysis of HFMD incidence hotspots from 2013 to 2022, Guangzhou was stratified into three zones: hotspot, random, and cold zones. Two districts were randomly selected from each zone, and from each district, two CHCs were randomly chosen. These selected CHCs were then randomly assigned to either the intervention or control group using computer-generated random numbers. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2025年3月15日于临床试验公共管理平台 ResMan (www.medresman.org) 公开原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The IPD will be made public on the clinical trial public management platform ResMan (www.medresman.org) on ??March 15, 2025 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
否 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
None |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |